(Q36834937)

16 August 2017

Characteristics of 10-year survivors of high-grade serous ovarian carcinoma (English)

1 reference

16 August 2017

4

Jenny Lester

1 reference

16 August 2017

11

Anil K Sood

1 reference

16 August 2017

Fanny Dao

1

1 reference

16 August 2017

Brooke A Schlappe

2

1 reference

16 August 2017

Jill Tseng

3

1 reference

16 August 2017

Alpa M Nick

5

1 reference

16 August 2017

Susan K Lutgendorf

6

1 reference

16 August 2017

Scott McMeekin

7

1 reference

16 August 2017

Robert L Coleman

8

1 reference

16 August 2017

Kathleen N Moore

9

1 reference

16 August 2017

Beth Y Karlan

10

1 reference

16 August 2017

Douglas A Levine

12

1 reference

16 August 2017

language of work or name

English

0 references

publication date

8 March 2016

1 reference

16 August 2017

1 reference

16 August 2017

141

1 reference

16 August 2017

2

1 reference

16 August 2017

260-263

1 reference

Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4844793

Characteristics of Long-Term Survivors of Epithelial Ovarian Cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4844793

Long-term survival advantage and prognostic factors associated with intraperitoneal chemotherapy treatment in advanced ovarian cancer: a gynecologic oncology group study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4844793

A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4844793

Comparative meta-analysis of prognostic gene signatures for late-stage ovarian cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4844793

Clinical implications of using molecular diagnostics for ovarian cancers

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4844793

Prognostically relevant gene signatures of high-grade serous ovarian carcinoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4844793

Rethinking ovarian cancer: recommendations for improving outcomes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4844793

Integrated genomic analyses of ovarian carcinoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4844793

A nomogram for estimating the probability of ovarian cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4844793

Validated gene targets associated with curatively treated advanced serous ovarian carcinoma.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4844793

A population-based 5-year cohort study including all cases of epithelial ovarian cancer in western Sweden: 10-year survival and prognostic factors

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4844793

Ten-year relative survival for epithelial ovarian cancer

5 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.010

Optimal (≤1 cm) but visible residual disease: is extensive debulking warranted?

7 January 2021

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.010

Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer

7 January 2021

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.010

10.1016/J.YGYNO.2016.03.010

7 January 2021

Identifiers

DOI

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

26968641

1 reference